Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study-Reference-Cited by-同舟云学术

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

Published:2008 Issue:2 Volume:23 Page:79-86
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Amiri Afshar,Noorbala Ahmad-Ali,Nejatisafa Ali-Akbar,Ghoreishi Abolfazl,Derakhshan Mohammad-Kamran,Khodaie-Ardakani Mohammad-Reza,Hajiazim Mohammad,Raznahan Maedeh,Akhondzadeh Shahin

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference19 articles.

1. Pharmacotherapy of Schizophrenia: The Past, Present and Future

2. A Randomized, 1-Year Follow-up Study of Olanzapine and Risperidone in the Treatment of Negative Symptoms in Outpatients with Schizophrenia

3. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. American Psychiatric Association: Washington, DC.

4. Treatment of Negative Symptoms in Schizophrenia and Schizoaffective Disorder by Selegiline Augmentation of Antipsychotic Medication

5. Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selegiline Improves Cognitive Impairment in the Rat Model of Alzheimer’s Disease;Molecular Neurobiology;2024-08-13

2. Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations;European Neuropsychopharmacology;2023-07

3. Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example;Advances in Neurobiology;2023

4. Effects of Blockade of Cholinesterase on Negative Disorders in Schizophrenia;Neuroscience and Behavioral Physiology;2022-06

5. Emerging evidence for astrocyte dysfunction in schizophrenia;Glia;2022-05-30